Results 191 to 200 of about 24,588 (279)

Omalizumab is effective and safe in chronic inducible urticaria (CIndU): Real‐world data from a large multi‐national UCARE study [PDF]

Reineke Soegiharto, Mehran Alizadeh Aghdam, Jennifer Astrup Sørensen, Esmee van Lindonk, Fatih Demir, Nasser Mohammad Porras, Yoshimi Matsuo, Lea Kiefer, André C. Knulst, Marcus Maurer, Karen Ritchie, Michael Rudenko, Emek Kocatürk, Roberta Fachini Jardim Criado, Stamatios Gregoriou, Tatjana Bobylev, Andreas Kleinheinz, Shunsuke Takahagi, Michihiro Hide, Ana M. Giménez‐Arnau, Andaç Salman, Rabia Öztaş Kara, Bahar Sevimli Dikicier, Martijn B. A. van Doorn, Simon Francis Thomsen, J. M. P. A. van den Reek, Heike Röckmann   +26 more
openalex   +1 more source

Real-world retrospective study on the efficacy and safety of anti-IgE therapy combined with rush immunotherapy in allergic asthma. [PDF]

Front Allergy
Zhang W, Liu D, Du W, Meng Z, Lin X, Guo W, Jin Y, Wang S, Zhang Q.   +8 more
europepmc   +1 more source

Predictors of response to omalizumab and relapse in chronic spontaneous Urticaria: a narrative review focusing on parameters available in routine clinical practice. [PDF]

Front Allergy
Mateu-Arrom L, Vence Nogueira XA, Puig L, Spertino J.   +3 more
europepmc   +1 more source

A Pilot Study of Omalizumab in Eosinophilic Esophagitis

, 2015
Denise Loizou, Benjamin Enav, Edina Komlódi-Pásztor, Pamela Hider, Julie J. Kim-Chang, Laura Noonan, Tabitha Taber, Suhasini Kaushal, Renuka P. Limgala, Margaret R. Brown, Raavi Gupta, Nader Balba, Özlem Göker-Alpan, Amer Khojah, Oral Alpan   +14 more
openalex   +2 more sources

Economic Impact of Biologics for Severe Asthma: A Case Series of 14 Patients From Northern Malaysia. [PDF]

Respirol Case Rep
Alaga A, Ismail IN.
europepmc   +1 more source

Combination of Omalizumab and Dupilumab for the Treatment of Severe Bullous Pemphigoid: a Series of 6 Cases. [PDF]

Acta Derm Venereol
Boisseau R, Scaramuzzino L, Bernard P, Bedane C, Fourmond S.   +4 more
europepmc   +1 more source

Comment on Manzoor, H. et al. Efficacy of Different Dosing Regimens of IgE Targeted Biologic Omalizumab for Chronic Spontaneous Urticaria in Adult and Pediatric Populations: A Meta-Analysis. Healthcare 2022, 10, 2579 [PDF]

Amin Tajerian
openalex   +1 more source

Distinct Effects of Biological Treatments on Eosinophils and Neutrophils in Chronic Rhinosinusitis With Nasal Polyp Patients. [PDF]

Clin Transl Allergy
Van Nevel S, Zhang N, Xu Z, Blauwblomme M, Vandewalle E, Holtappels G, De Ruyck N, Van Nieuwerburgh F, Vanhee S, Gevaert P, Bachert C.   +10 more
europepmc   +1 more source

Expanding treatment options in chronic spontaneous urticaria: the emerging role of dupilumab. [PDF]

Ann Med Surg (Lond)
Fathima Haseena H, Kumari S, Jaber Amin MH.   +2 more
europepmc   +1 more source

Dynamic Changes in Type 2 Inflammatory Markers Correlated with Clinical Outcomes in T2-High Severe Asthma Treated with Omalizumab and Mepolizumab [PDF]

Chia-Wei Chang, Si‐Yuan Wu, Shin-En Tang, Chen‐Liang Tsai, Chia-Hsin Liu   +4 more
openalex   +1 more source